Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 ...

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus ...

Shares of Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) climbed about 9.3% in premarket trading on Wednesday after the company unveiled plans to expand into India, marking its first move beyond the U.

The partnership marks Cardio Diagnostics' first expansion outside the US and is focused on integrating the test within Dr. Lal PathLabs' laboratory and clinical network.

The launch comes at a time when Dr Lal PathLabs continues to rely on volume-led growth, having not taken a price hike in the ...

Investing.com -- Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) stock rose 9.3% in premarket trading Wednesday after the company announced a strategic agreement to launch its PrecisionCHD test in India ...

Dr Lal PathLabs announced the launch of Sovaaka, a Diagnostic Experience Centre, in Gurugram. The launch event was attended ...

Dr Lal PathLabs launches Sovaaka, a next-generation wellness centre of science, technology, and personalized care: Our Bureau, Bengaluru Tuesday, January 6, 2026, 17:30 Hrs [IST] ...

Diagnostic chains are expanding laboratories, integrated centres and collection networks as demand grows for preventive, ...

Dr Lal PathLabs is set to see a sharp decline in its quoted share price on Friday, December 19, as the stock turned ex-date for its maiden bonus issue.

Dr. Lal’s strong execution in core markets, expansion into new geographies, and innovation-led portfolio enhancement underpin ...